BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 18942556)

  • 1. [Left main coronary artery stenosis].
    Sheiban I; Biondi-Zoccai GG; Moretti C
    G Ital Cardiol (Rome); 2008 Oct; 9(10):684-9. PubMed ID: 18942556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary intervention for unprotected left main coronary artery stenosis.
    Park SJ; Kim YH
    Cardiol Clin; 2010 Feb; 28(1):81-95. PubMed ID: 19962051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revascularization of unprotected left main coronary artery disease with percutaneous coronary intervention: the role of drug-eluting stents.
    Kirtane AJ; Chieffo A; Magni V; Mehran R; Colombo A; Moses JW
    Minerva Cardioangiol; 2008 Feb; 56(1):43-53. PubMed ID: 18432168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era: a report from the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR).
    Huang HW; Brent BN; Shaw RE
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):867-72. PubMed ID: 17080468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical results of unprotected left main coronary stenting.
    Ben-Dor I; Vaknin-Assa H; Lev E; Brosh D; Fuchs S; Assali A; Kornowski R
    Isr Med Assoc J; 2009 Mar; 11(3):154-9. PubMed ID: 19544705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stenting of unprotected left main coronary artery stenosis.
    Barlis P; Wong MC; Clark DJ
    Heart Lung Circ; 2007; 16 Suppl 3():S34-8. PubMed ID: 17606402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents.
    Kim YH; Park DW; Lee SW; Yun SC; Lee CW; Hong MK; Park SW; Seung KB; Gwon HC; Jeong MH; Jang Y; Kim HS; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ;
    Circulation; 2009 Aug; 120(5):400-7. PubMed ID: 19620506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.
    Capodanno D; Di Salvo ME; Capranzano P; Seminara D; Caggegi A; Barrano G; Tamburino C
    Minerva Cardioangiol; 2009 Feb; 57(1):1-6. PubMed ID: 19202514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left main coronary artery disease: is CABG still the gold standard?
    Ng MK; Yeung AC
    Rev Cardiovasc Med; 2005; 6(4):187-93. PubMed ID: 16379014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year (mid-term) results for unprotected left main coronary artery percutaneous interventions with drug-eluting stents.
    Yarkoni A; Brodsky A; Sabapathy R; Pershad A
    Indian Heart J; 2008; 60(3):195-9. PubMed ID: 19240306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex coronary interventions: unprotected left main and bifurcation lesions.
    Barlis P; Tanigawa J; Kaplan S; di Mario C
    J Interv Cardiol; 2006 Dec; 19(6):510-24. PubMed ID: 17107366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous coronary revascularization in diabetics: from balloon angioplasty to drug-eluting stents.
    Jiménez-Quevedo P; Sabaté M
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):635-46. PubMed ID: 16076274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Unprotected left main coronary artery stenting: immediate and medium-term outcomes of 24 procedures].
    Puymirat E; Labèque JN; Coste P
    Ann Cardiol Angeiol (Paris); 2008 Aug; 57(4):195-200. PubMed ID: 18550024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous revascularization is the preferred strategy for patients with significant left main coronary stenosis.
    Teirstein PS
    Circulation; 2009 Feb; 119(7):1021-33. PubMed ID: 19237673
    [No Abstract]   [Full Text] [Related]  

  • 16. Percutaneous coronary intervention for left main coronary artery disease.
    Gauthier N; Le May MR
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):213-20. PubMed ID: 17338666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is stenting a preferred option for unprotected left main coronary artery disease in the drug-eluting stent era?
    Park SJ
    Indian Heart J; 2007; 59(2 Suppl B):B105-12. PubMed ID: 19153426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic coronary multi-vessel disease with left main artery stenosis: For PCI].
    Hamm CW
    Dtsch Med Wochenschr; 2010 Apr; 135(13):626. PubMed ID: 20333600
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter by Pocar et al regarding article, "Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience".
    Pocar M; Quaini E; Donatelli F
    Circulation; 2006 Nov; 114(19):e574; author reply e575. PubMed ID: 17088470
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter by Brocco et al regarding article, "Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience".
    Brocco S; Spolaore P; Tarantini G
    Circulation; 2006 Nov; 114(19):e573; author reply e575. PubMed ID: 17088469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.